A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women

Eur J Contracept Reprod Health Care. 2012 Oct;17(5):340-50. doi: 10.3109/13625187.2012.700744. Epub 2012 Jul 26.


Objectives: Intrauterine contracepives (IUCs) are highly effective and safe for use in all women, including those who are nulliparous. However, many myths and barriers prevent more widespread utilisation. The objective of this article was to explore the health care provider (HCP), health system and user issues that prevent more widespread use of IUCs, particularly among nulliparous women, and to present the evidence that supports achieving greater utilisation of these devices.

Methods: MEDLINE, PubMed and Embase were used to identify studies reporting attitudes and beliefs around IUCs, and clinical studies providing evidence of their risks and benefits.

Results: HCP, health system and user factors limiting use of IUCs were identified. The most widely explored barriers in published studies are those at the HCP level. User barriers are less well documented and health system barriers are mostly assessed through indirect evidence. Many, but not all, of the barriers can be reduced through greater understanding of the evidence.

Conclusions: Efforts need to be made to disseminate the evidence, which shows that few contraindications exist to IUC use. Addressing HCP lack of knowledge, training and confidence with IUC insertions, particularly in nulliparous women, could make a substantial positive impact on IUC utilisation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Attitude of Health Personnel
  • Contraceptive Agents, Female* / therapeutic use
  • Contraindications
  • Evidence-Based Medicine
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Infertility, Female / drug therapy*
  • Intrauterine Devices / statistics & numerical data*
  • Mythology
  • Parity*
  • Practice Patterns, Physicians'
  • Pregnancy
  • Primary Health Care*
  • Prospective Studies
  • Risk Factors
  • Workforce


  • Contraceptive Agents, Female